GCM
RMD icon

Gallacher Capital Management’s ResMed RMD Stock Holding History

Gallacher Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,120
Closed -$251K – 333
2026
Q1 		$251K Buy
+1,120
New +$279K 0.1% 259
2025
Q3 		– Sell
-1,032
Closed -$266K – 342
2025
Q2 		$266K Sell
1,032
-972
-49% -$232K 0.12% 228
2025
Q1 		$449K Buy
+2,004
New +$468K 0.22% 130

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Gallacher Capital Management's RMD Position: Q2 2026 in Review

Gallacher Capital Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,120 shares — an estimated $251K sold.

Gallacher Capital Management first reported a position in RMD in Q1 2025 and held it in 3 quarters. The position peaked at $449K in Q1 2025. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Gallacher Capital Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Gallacher Capital Management sold 1,120 ResMed shares in Q2 2026, an estimated $251K.
  • Gallacher Capital Management first reported a position in ResMed in Q1 2025 and held it in 3 quarters.
  • Gallacher Capital Management's ResMed position peaked at $449K in Q1 2025.
  • 141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.